Patent Yard Sign in
Canadian application, no grantCanada

Lipocalin homologs

CA 2298439 A1 · Owner: Conklin, Darrell C. · Inventors: Conklin, Darrell C.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention is directed to polynucleotides and polypeptides for a novel member of the lipocalin family. The expression of this novel polynucleotide is restricted to testis and mammary gland particularly breast , tumor tissue. The polypeptide has been designated zlipo1. The present invention also includes antibodies to the zlipo1 polypeptides.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 6, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 6, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 6, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 6, 1998
GrantedNo grant recorded
Term endedAugust 6, 2018
Patent numberCA 2298439 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedAug 6, 1998Term endedAug 6, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.